Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2392-2400

  Huang, Binbin ^a   Sun, Longe ^a   Cao, Jianchun ^a   Zhang, Yunyun ^a   Wu, Qiong ^a   Zhang, Junjie ^a   Ge, Yanli ^a   Fu, Liu ^a   Wang, Zhirong ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gastric cancer; Invasion; Metastasis; N acetylglucosaminyltransferase V

Indexed keywords

ALPHA 1,3(6) MANNOSYLGLYCOPROTEIN BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; ASPARAGINE; BETA1-6 BRANCHED N OLIGOSACCHARIDE; CHOLECYSTOKININ OCTAPEPTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; LECTIN; MESSENGER RNA; N ACETYLGLUCOSAMINYLTRANSFERASE; OLIGOSACCHARIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL STRAIN BGC823; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GASTRIC METASTASIS; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; METASTASIS INHIBITION; NICK END LABELING; ONCOGENE; ONCOGENE GNT V; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STOMACH CANCER;

CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GLYCOSYLATION; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; VIMENTIN;

EID: 84876259688     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2373     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Nagini S: Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol 4: 156-169, 2012.
3. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ and Ezzati M; Comparative Risk Assessment collaborating group (cancers): Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366: 1784-1793, 2005. (Pubitemid 41642642)
4. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol Hematol 71: 127-164, 2009.
5. Przybyło M, Pocheć E, Link-Lenczowski P and Lityńska A: Beta 1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility. Mol Vis 14: 625-636, 2008.
6. Murata K, Miyoshi E, Kameyama M, et al: Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 6: 1772-1777, 2000. (Pubitemid 30305070)
7. Guo P, Chen HJ, Wang QY and Chen HL: Downregulation of N-acetylglucosaminyltransferase V facilitates all-trans retinoic acid to induce apoptosis of human hepatocarcinoma cells. Mol Cell Biochem 284: 103-110, 2005.
8. Xu YY, Lu Y, Fan KY and Shen ZH: Apoptosis induced by all-trans retinoic acid in N-acetylglucosaminyltransferase V repressed human hepatocarcinoma cells is mediated through endoplasmic reticulum stress. J Cell Biochem 100: 773-782, 2007. (Pubitemid 46180538)
9. Dosaka-Akita H, Miyoshi E, Suzuki O, Itoh T, Katoh H and Taniguchi N: Expression of N-acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res 10: 1773-1779, 2004. (Pubitemid 38443329)
10. Ishimura H, Takahashi T, Nakagawa H, et al: N- acetylglucsaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin Cancer Res 12: 2506-2511, 2006.
11. Inamori K, Gu J, Ohira M, et al: High expression of N- acetylglucosaminyltransferase V in favorable neuroblastomas: involvement of its effect on apoptosis. FEBS Lett 580: 627-632, 2006. (Pubitemid 43089697)
12. Tian H, Miyoshi E, Kawaguchi N, et al: The implication of N-acetylglucosaminyltransferase V expression in gastric cancer. Pathobiology 75: 288-294, 2008.
13. Hsieh CY, Tsai PC, Tseng CH, Chen YL, Chang LS and Lin SR: Inhibition of EGF/EGFR activation with naphtho(1,2-b)furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells. Toxicol In Vitro 27: 1-10, 2013.
14. Baselga J and Arteaga CL: Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 23: 2445-2459, 2005. (Pubitemid 47050835)
15. Rothhut B, Ghoneim C, Antonicelli F and Soula-Rothhut M: Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through focal adhesion kinase. Biochimie 89: 613-624, 2007. (Pubitemid 46680369)
16. Mascia F, Cataisson C, Lee TC, et al: EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. J Invest Dermatol 130: 682-693, 2010.
17. Pastore S, Mascia F, Mariani V and Girolomoni G: The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128: 1365-1374, 2008. (Pubitemid 351693180)
18. Pastore S and Mascia F: Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol 3: 525-527, 2008.
19. Kimura A, Terao M, Kato A, et al: Upregulation of N- acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia. Exp Dermatol 21: 515-519, 2012.
20. Zhao Y, Sato Y, Isaji T, et al: Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J 275: 1939-1948, 2008. (Pubitemid 351569538)
21. Gu J, Zhao Y, Isaji T, et al: Beta1,4-N-acetylglucosaminyltransferase III down-regulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras/ERK signaling pathway in PC12 cells. Glycobiology 14: 177-186, 2004. (Pubitemid 38263102)
22. Zhao Y, Nakagawa T, Itoh S, et al: N-acetylglucosaminyl transferase III antagonizes the effect of N-acetylglucosaminyl transferase V on α3β1 integrin-mediated cell migration. J Biol Chem 281: 32122-32130, 2006. (Pubitemid 46036766)
23. Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF and Hudson LG: Differential downregulation of E-cadherin and desmoglein by epidermal growth factor. Dermatol Res Pract 2012: 309587, 2012.
24. Terao M, Ishikawa A, Nakahara S, et al: Enhanced epithelial-mesenchymal transition-like phenotype in N-acetylglucosaminyltransferase V transgenic mouse skin promotes wound healing. J Biol Chem 286: 28303-28311, 2011.
25. Zeisberg M and Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437, 2009.
26. Dilly M, Hambruch N, Haeger JD and Pfarrer C: Epidermal growth factor (EGF) induces motility and upregulates MMP-9 and TIMP-1 in bovine trophoblast cells. Mol Reprod Dev 77: 622-629, 2010.
27. Delassus GS, Cho H, Park J and Eliceiri GL: New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells. J Cell Physiol 217: 739-744, 2008.
28. Fink K and Boratyński J: The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis. Postepy Hig Med Dosw (Online) 66: 609-628, 2012 (In Polish).
29. Partridge JJ, Madsen MA, Ardi VC, Papagiannakopoulos T, Kupriyanova TA, Quigley JP and Deryugina EI: Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis. J Biol Chem 282: 35964-35977, 2007. (Pubitemid 350277143)
30. Di Carlo A: Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma. Oncol Rep 28: 1051-1056, 2012.
31. Zhuo E, He J, Wei T, et al: Down-regulation of GnT-V enhances nasopharyngeal carcinoma cell CNE-2 radiosensitivity in vitro and in vivo. Biochem Biophys Res Commun 424: 554-562, 2012.
32. Beheshti Zavareh R, Sukhai MA, Hurren R, et al: Suppression of cancer progression by MGAT1 shRNA knockdown. PLoS One 7: e43721, 2012.
33. Xu Q, Isaji T, Lu Y, et al: Roles of N-acetylglucosaminyltrans-ferase III in epithelial-to-mesenchymal transition induced by transforming growth factor β1 (TGF-β1) in epithelial cell lines. J Biol Chem 287: 16563-16574, 2012.
34. + T cells and macrophages. J Immunol 180: 3158-3165, 2008.
35. Pinho SS, Reis CA, Paredes J, et al: The role of N- acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet 18: 2599-2608, 2009.
36. Pinho SS, Seruca R, Gärtner F, Yamaguchi Y, Gu J, Taniguchi N and Reis CA: Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol Life Sci 68: 1011-1020, 2011.
37. Zhao H, Liang Y, Xu Z, et al: N-glycosylation affects the adhesive function of E-Cadherin through modifying the composition of adherens junctions (AJs) in human breast carcinoma cell line MDA-MB-435. J Cell Biochem 104: 162-175, 2008.
38. Liu T, Zhang X, Shang M, et al: Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. J Surg Oncol 107: 188-194, 2013.
39. Roberti MP, Arriaga JM, Bianchini M, et al: Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice. Cancer Biol Ther 13: 1123-1140, 2012.